Epigenetics refers to the study of heritable changes in gene expression that do not involve alterations in the DNA sequence itself. Epigenetic mechanisms control how genes are turned on or off in response to environmental or developmental signals. These changes can have profound effects on cell function and contribute to various diseases.

Key epigenetic mechanisms include:

1. DNA Methylation: The addition of methyl groups to cytosine bases in DNA, typically silencing gene expression.
2. Histone Modification: Post-translational modifications of histone proteins (such as acetylation, methylation, phosphorylation) that affect how tightly DNA is wrapped around histones, regulating gene accessibility.
3. Non-coding RNAs: Small RNAs (like microRNAs) that regulate gene expression post-transcriptionally by binding to mRNA, leading to its degradation or suppression of translation.

Epigenetic Regulation and Human Disease

Epigenetic changes can either contribute to disease development or result from disease conditions. These modifications can alter gene expression without changing the DNA sequence, leading to the activation or repression of critical genes involved in disease processes.

Examples of Conditions Linked to Epigenetic Regulation:

1. Cancer:
   • Hypermethylation of tumor suppressor genes (e.g., p16, BRCA1) can silence their expression, contributing to uncontrolled cell growth and tumorigenesis.
   • Hypomethylation of oncogenes (e.g., Ras) can lead to their overexpression, promoting cancer progression.
   • Histone modifications can affect chromatin structure and gene expression, leading to oncogenic changes in cell proliferation, apoptosis, and DNA repair.
2. Example: In colorectal cancer, MLH1 gene hypermethylation can cause defective DNA mismatch repair, leading to microsatellite instability (MSI) and tumorigenesis.
3. Neurodegenerative Disorders:
   • Alzheimer's disease is linked to epigenetic dysregulation, particularly altered DNA methylation and histone modifications. Aberrant methylation of genes related to amyloid precursor protein (APP) and tau protein can contribute to the development of Alzheimer's pathology.
   • Parkinson's disease also shows altered epigenetic profiles, with dysregulation of genes involved in neuroinflammation and dopamine signaling.
   • Spinocerebellar ataxia-7 (increased number of CAG repeats in ATXN7 affecting histone acetylation) - a condition causing dysarthria, dysphagia and blindness
4. Immunological Disorders:
   • Systemic lupus erythematosus (SLE) is associated with altered DNA methylation patterns, especially hypomethylation in T cells, which leads to the overexpression of immune-related genes, driving autoimmunity.
   • In rheumatoid arthritis, abnormal DNA methylation and histone modifications can lead to pro-inflammatory gene expression in synovial fibroblasts and immune cells.
5. Metabolic Disorders:
   • Type 2 diabetes (T2DM) has been linked to changes in DNA methylation patterns in genes involved in insulin resistance and beta-cell function (e.g., PPARγ).
   • Obesity is influenced by epigenetic changes in genes regulating metabolism and fat storage (e.g., LEP for leptin).
6. Cardiovascular Diseases:
   • Atherosclerosis is influenced by epigenetic modifications affecting the expression of genes involved in lipid metabolism, inflammation, and vascular repair (e.g., ABCA1, ICAM1).
   • Hypertension has been linked to altered DNA methylation and histone modification patterns that affect genes controlling blood pressure regulation and vascular function.
7. Developmental Disorders:
   • Rett syndrome, a neurodevelopmental disorder causing mental retardation in young girls, is a result of mutations in the MECP2 gene, which is a key player in epigenetic regulation via methylation-dependent gene silencing.
   • Beckwith-Wiedemann syndrome (BWS) is linked to abnormal imprinting (an epigenetic process) of genes on chromosome 11, leading to overgrowth and cancer predisposition.
   • Cockayne-B syndrome (mutations in ERCC6 changing the ATPase and chromatin-remodelling activities) - characterised by progeroid features, growth failure and photosensitivity
8. Psychiatric Disorders:
   • Schizophrenia and bipolar disorder have been associated with epigenetic dysregulation in genes involved in neurodevelopment and synaptic function. For instance, altered methylation of the BDNF (brain-derived neurotrophic factor) gene is observed in psychiatric conditions.
   • Depression has been linked to the dysregulation of stress-response genes, such as FKBP5, through DNA methylation changes.

Key Concepts for MRCP UK and Clinical Use:

• Cancer: Epigenetic therapies such as DNA methylation inhibitors (e.g., azacitidine) and histone deacetylase inhibitors (HDACi) are used in the treatment of myelodysplastic syndrome, leukemia, and other cancers.
• Pharmacogenomics: Epigenetic changes can influence drug metabolism and response, making it relevant in personalized medicine.
• Environmental Influences: Epigenetics is influenced by diet, lifestyle, and environmental factors, meaning that both genetic predisposition and environment play a role in disease development.